Document:

Ex-10.1

 

Exhibit 10.1

CONSULTING AGREEMENT

     This Consulting Agreement (the “Agreement”) is entered into as of the 4th day of August, 2006
(the “Effective Date”), by and between MEDCATH INCORPORATED, a Delaware corporation (“MedCath”),
and SSB SOLUTIONS (“Consultant”).

R E C I T A L S

     A. MedCath desires to retain Consultant as a consultant to MedCath;

     B. Consultant is willing to provide Consulting Services (defined below) to MedCath as
requested by MedCath and agreed upon by Consultant from time to time; and

     C. The parties desire for Consultant to provide Consulting Services in accordance with the
terms and conditions set forth herein;

A G R E E M E N T

     NOW, THEREFORE, in consideration of the foregoing recitals and the promises set forth herein,
the parties hereto agree as follows:

	1	 	RETENTION OF CONSULTANT.

     MedCath hereby retains Consultant to provide the Consulting Services and Consultant hereby
accepts and agrees to perform such Consulting Services pursuant to the terms and conditions of this
Agreement. Consultant shall coordinate the performance of his Consulting Services with MedCath’s
Chief Executive Officer (the “CEO”) or other representatives as may be designated by the CEO from
time to time. Since a principal owner and an officer of Consultant, Jacque J. Sokolov, M.D. (“Dr.
Sokolov”) is also a director of MedCath, the parties acknowledge that any compensation due
hereunder is for Consulting Services and not for any services which Dr. Sokolov may provide to
MedCath in his capacity as a member of the Board of Directors.

	2.	 	OBLIGATIONS OF CONSULTANT.

     2.1 Consulting Services. Consultant shall perform services based upon the following
guidelines (the “Consulting Services”), which may be amended from time to time upon the mutual
written consent of MedCath and Consultant:

     (a) Each consulting assignment shall be proposed by the CEO and agreed upon by
Consultant at which time the CEO and Consultant shall agree the scope of the assignment, the
amount of Consultant’s time needed to complete the work, the completion date, the location
or MedCath facility on which the assignment is focused and other relevant information;

 

 

     (b) Since Dr. Sokolov is also a member of the Board of Directors of MedCath
Corporation, Consultant will inform other individuals or parties involved in each assignment
that Dr. Sokolov and Consultant are working in the capacity of an independent consultant,
and not in the capacity of a member of the Board of Directors of MedCath Corporation;

     (c) In order to avoid conflicts of interest, Consultant will disclose to the CEO if
Consultant or any of its affiliates has or is seeking a business relationship with any third
party that might be involved in or be the subject of any of the Consulting Services if
MedCath or any of its affiliates is also negotiating or seeking to enter into a relationship
with such third party, in which event Consultant shall not perform services under this
Agreement for MedCath or its affiliates.

     (d) Consultant will also first disclose to the CEO if Consultant or any of its
affiliates desires to provide services to, or to seek a business relationship with, any
third party that has a pre-existing relationship or agreement or with MedCath or any of its
affiliates. In such an event, only if Consultant obtains CEO’s prior written consent, may
Consultant enter into a relationship or agreement with such third party, in which event such
consulting relationship shall be solely between Consultant and such third party who shall be
responsible for the payment of any fees due to Consultant. Consultant will inform other
individuals or parties involved in such arrangements that he is working in the capacity of
an independent consultant, and not in the capacity of a member of the Board of Directors of
MedCath Corporation. MedCath and its affiliates shall have no liability or responsibility
for any consulting work or other relationship between Consultant and any other such third
parties.

	3	 	COMPENSATION.

     3.1 Fees. As compensation for the Consulting Services provided under this Agreement,
MedCath shall pay Consultant an hourly rate of $575.00 which amount shall be paid for assignments
approved hereunder. Consultant shall submit an invoice each month accompanied by documentation
which evidences the applicable assignment, the time spent and description of duties performed by
Consultant during the month for which compensation is to be paid. All travel time will be at the
rate of $282.50 per hour and travel time shall not exceed more than 5 hours for each requested
travel segment although most travel segments will be 2 to 4 hours. MedCath shall pay Consultant
within thirty (30) days after receipt and reasonable approval of each invoice by the CEO. Such
invoices thereafter shall be reviewed by the Audit Committee.

     3.2 Expenses. MedCath shall reimburse Consultant for his direct out-of-pocket
expenses reasonably incurred in connection with Consultant’s performance of the Consulting
Services, including reasonable travel expenses based upon the travel and reimbursement policies and
practices applicable to MedCath’s employees.

2

 

     3.3 Income and Employment Taxes. Consultant shall be solely responsible for payments
and reporting of all taxes on compensation in whatever form paid hereunder, in accordance with the
requirements of applicable law.

	4	 	TERM AND TERMINATION.

     4.1 Term. This Agreement shall continue from month to month until terminated as
provided in Section 4.2 below, the term of this Agreement (the “Term”).

     4.2 Termination.

     (a) This Agreement shall be terminated as follows:

     (i) By either party by written notice to the other party of a breach by such
party of any material provisions of this Agreement which breach is not cured within
15 days of written notice thereof; or

     (ii) At any time without cause upon thirty (30) days prior written notice to
the other party hereto.

     (b) Termination of this Agreement shall not release or discharge either party from any
obligation, debt or liability which shall have previously accrued and remain to be performed
on or after the date of termination, including but not limited to payment of fees due to
Consultant for work performed prior to the effective date of termination.

	5	 	NON-DISCLOSURE, NEW DEVELOPMENTS AND NON-SOLICITATION.

     5.1 Non-Disclosure. The Consultant acknowledges and agrees that the information
provided to the Consultant both before and after the Effective Date by MedCath or any of its
affiliated hospitals, facilities, clinics, medical practices or any of their officers, directors or
investors (individually, an “Affiliate” and collectively, the “Affiliates”) including, without
limitation, agreements governing Affiliates, the MedCath business model, the ownership structure of
MedCath or any Affiliate, all patient information, the terms of this Agreement, all policies and
procedures of MedCath or any of its Affiliates, information relating to the medical, clinical and
administrative operations of any MedCath facility, all MedCath financial information, MedCath’s
strategic, business and marketing plans, credentialing information, utilization information, all
plans and designs for any MedCath facility, terms of any provider agreements, terms of any facility
agreements, relationships with vendors, and terms of other agreements to which MedCath is a party,
the identity of all investors in MedCath or any of its Affiliates, all records, files, reports and
documents pertaining to services rendered by Consultant hereunder shall constitute “Confidential
Information” and shall remain the property of MedCath. During the term of this Agreement and at
all times thereafter, the Consultant shall not use for his own benefit nor allow to be used for the
benefit of any other party, directly or indirectly, any of the Confidential Information and shall
keep all such information confidential and shall not disclose it to any other party other than at
the direction of MedCath. The Consultant acknowledges that the Confidential Information is unique
and proprietary to MedCath and
provides a significant competitive

3

 

advantage to MedCath which would be lost if the Consultant does
not fulfill his obligations hereunder. The restrictions of this Section shall not apply to
information which (i) is generally available to the public other than as a result of a breach by
Consultant of the confidentiality provisions contained herein, (ii) becomes available on a
non-confidential basis from a source other than Consultant or MedCath, or (iii) which is required
to be disclosed by law or pursuant to court order.

     If Consultant desires to obtain any Confidential Information or any Development (as defined
below) and/or to use it or any for any purpose other than for the benefit of MedCath, Consultant
shall make a request therefore to the CEO whose written consent may be given or withheld in his
discretion.

     5.2 New Developments. Consultant agrees that any and all developments and work
product created by Consultant in the course of Consultant’s performance under this Agreement or
arising from the performance by Consultant under this Agreement, including but not limited to
methods of doing business, transaction structures, terms of agreements, patentable inventions and
any material which may be protected by copyright, trademark, service mark, or other intellectual
property protection (hereinafter a “Development” or if more than one, the “Developments”) shall be
the exclusive property of MedCath, without any obligation of payment to Consultant. Consultant
shall not use any such Developments other than for the benefit of MedCath and other than at the
MedCath’s written direction.

     5.3 Non-Solicitation of Employees. During the term of this Agreement and for two (2)
years after the termination hereof for any reason, without the consent of the other party hereto,
neither party shall, and shall not permit its Affiliates to solicit for hire, or to hire, as an
employee any individual who was employed by either a party hereto or by one of its Affiliates
during the term of this Agreement unless such individual’s employment was first terminated by a
party hereto.

     5.4 Remedies. If there is a breach or threatened breach of the provisions of this
Section 5 of this Agreement, in addition to other remedies at law or equity, the non-breaching
party shall be entitled to injunctive relief. The parties desire and intend that the provisions of
this Section 5 shall be enforced to the fullest extent permissible under the law and public
policies applied, but the unenforceability or modification of any particular paragraph,
subparagraph, sentence, clause, phrase, word, or figure shall not be deemed to render unenforceable
the remainder of this Section 5. Should any such paragraph, subparagraph, sentence, clause,
phrase, word, or figure be adjudicated to be wholly invalid or unenforceable, a court with
applicable authority is hereby authorized to “blue pencil” or modify this Section 5 or any portion
hereof so that the balance of this Section 5 shall thereupon be modified in order to render the
same valid and enforceable and the unenforceable portion of this Section 5 shall be deemed to have
been deleted from this Agreement.

	6	 	ACCESS TO BOOKS AND INFORMATION.

     Consultant shall make this Agreement and the books, documents and records pertaining to
Consulting Services provided under this Agreement available to the Secretary of Health and

4

 

Human Services, the Comptroller General, or their duly authorized representatives as required by
law for four (4) years after the termination of this Agreement.

	7	 	MISCELLANEOUS.

     7.1 No Conflict; Compliance with Laws. Consultant represents that he is not subject
to any pre-existing obligation that would conflict with the terms of this Agreement or restrict or
prevent Consultant from performing his obligations hereunder. Consultant shall perform his duties
under this Agreement in accordance with (a) all applicable federal and state statutes and
regulations and (b) all applicable MedCath policies, procedures and directives as may be in effect
from time to time.

     7.2 Independent Contractor. It is mutually understood that Consultant will perform
his duties and obligations hereunder as an independent contractor and not as a partner, joint
venture, or employee of MedCath.

     7.3 Governing Law. This Agreement shall be governed by and interpreted in accordance
with the laws of the State of North Carolina without regard to its conflict of laws principles.

     7.4 Severability. If any provision of this Agreement shall be declared invalid or
illegal for any reason whatsoever, then notwithstanding such invalidity or illegality, the
remaining terms and provisions of this Agreement shall remain in full force and effect in the same
manner as if the invalid or illegal provision had not been contained herein.

     7.5 Entire Agreement and Amendment. This Agreement contains all of the terms and
conditions agreed upon by the parties with respect to the subject matter hereof. No other
understanding regarding the subject matter of this Agreement shall be deemed to exist or to bind
either party. No alteration or modification of this Agreement, including the exhibits attached
hereto, shall be valid unless made in writing and executed by each of the parties hereto.

     7.6 Counterparts. This Agreement may be executed in any number of counterparts with
the same effect as if all of the parties had signed the same document. Such executions may be
transmitted to the parties by facsimile and such facsimile execution shall have the full force and
effect of an original signature. All fully executed counterparts, whether original executions or
facsimile executions or a combination, shall be construed together and shall constitute one and the
same agreement.

     7.7 Assignment; Binding Effect. Consultant shall not assign any rights or delegate
any duties under this Agreement without the prior written consent of MedCath. Any unauthorized
attempted assignment by Consultant shall be null and void and of no force or effect. MedCath shall
have the right to assign any rights or delegate any duties under the Agreement upon written notice
to Consultant, to any party controlled by, controlling, or under common ownership with MedCath.
This Agreement shall be binding upon and shall inure to the benefit of the parties and their
respective successors and representatives. Any assignment

5

 

permitted under this Section shall have no effect on the terms of this Agreement, including Section
3, unless expressly agreed in a written amendment to this Agreement.

     7.8 Notices. Any notices or written communications to be given hereunder by either
party to the other shall be deemed to be received by the intended recipient (a) when delivered
personally, (b) the day following delivery to a nationally recognized overnight courier service
with proof of delivery, or (c) three days after mailing by certified mail, postage prepaid with
return receipt requested, in each case addressed to the parties as set forth below:

	 	 	 
	If to Consultant:

	 	SSB Solutions

5685 N. Scottsdale Rd., Ste E-100

Scottsdale, AZ 85250

Attention: Jacque J. Sokolov, MD
	 
	 	 
	If to MedCath:

	 	MedCath Incorporated

10720 Sikes Place, Suite 300

Charlotte, North Carolina 28277

Attention: CEO

Any party may change the address for notice by notifying the other party, in writing, of the new
address.

     7.9 Waiver of Breach. No waiver of any of the provisions of this Agreement shall be
deemed to be or shall constitute a waiver of any other provision hereof, nor shall such waiver
constitute a continuing waiver unless otherwise expressly provided.

     7.10 Survival. The covenants contained in Sections 5 and 6 shall survive any
termination or expiration of this Agreement for any reason.

[SIGNATURES ON FOLLOWING PAGE]

6

 

     IN WITNESS WHEREOF, the parties have entered into this Agreement as of the date first above
written.

	 	 	 	 	 
	 

	 	MEDCATH INCORPORATED
	 
	 	 	 	 
	 

	 	By:
	 	/s/ O. Edwin French
	 
	 	 	 	 
	 

	 	Name:
	 	O. Edwin French

	 
	 	 	 	 
	 

	 	Title:
	 	President and CEO
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	SSB SOLUTIONS
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jacque J. Sokolov, M.D.
	 

	 	 	 	Jacque J. Sokolov, M.D.

7EX-10.1 FIRST AMENDMENT TO AGCO CORPORATION

 

Exhibit 10.1

FIRST AMENDMENT TO

AGCO CORPORATION

2006 LONG TERM INCENTIVE PLAN

(As adopted July 27, 2006)

     Pursuant to Article IX of the 2006 AGCO Long Term Incentive Plan (the “Plan”), the Plan
is amended as follows effectively immediately:

     1. Section 2.18 of the Plan is amended by deleting the first sentence thereof and replacing it
with the following:

The term “Performance Period” means with respect to an Award, a period of not less than one
year within which the Performance Measures relating to such Award are to be measured.
Notwithstanding the foregoing, up to 250,000 Performance Shares may have Performance
Periods that are less than one year.”

     2. Article IX of the Plan shall be amended by adding at the end thereof the following:

Notwithstanding the foregoing, no amendment that (i) materially increases the benefits
accruing to participants under the Plan, or (ii) materially expands the definition of
Eligible Employee shall be effective until such amendment has been approved by stockholders
of the Company.

     IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly
authorized officer this 27th day of July, 2006.

	 	 	 	 	 	 	 
	 	 	AGCO CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Stephen Lupton	 	 
	 

	 	 	 	 	 	 
	 

	 	Title:
	 	Senior Vice President and	 	 
	 

	 	 	 	  General Counsel

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]